Lakeside Opens New Neurosciences Center
July 1st, 2011
Lakeside Behavioral Health System is pleased to announce the opening of its new Neurosciences Center for Treatment-Resistant Conditions and the addition of Transcranial Magnetic Stimulation (TMS) to the current offering of electroconvulsive therapy (ECT).
“This expansion will allow us to serve a greater number of patients who are experiencing treatment-resistant conditions and give them hope that a positive, productive life is available,” stated Shelley Nowak, CEO.
For many years, Lakeside has offered ECT for the treatment of severe depression and mania, schizophrenia and catatonia. The addition of TMS allows Lakeside to reach patients with a non-invasive, non-drug outpatient treatment for major depressive disorder. These patients typically have received little or no results with their current treatment protocol.
“TMS provides a fast, safe and almost immediate relief to patients who are dealing with major depressive disorder,” said Joy Golden, Chief Operating Officer. “Patients are treated in an outpatient setting, so no hospital stay is required, and they can return to normal activities following treatment.”
Lakeside has appointed Dr. Dan Boyd as the Medical Director for the Neurosciences Center. He is a graduate of Baylor College of Medicine, completed his residency in Psychiatry at Vanderbilt University and is Board Certified by the American Board of Psychiatry and Neurology. He is one of only two psychiatrists in the Mid-South area certified for electroconvulsive therapy (ECT), and most recently was certified to perform Transcranial Magnetic Stimulations (TMS), both of which will be included in the new Neuroscience Center.